Top Banner
© 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph A. Loren Partner [email protected]
24

© 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Dec 16, 2015

Download

Documents

Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

© 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP

IP Issues in TransactionsF.I.R.E. Series, University of RochesterMay 14, 2013

Ralph A. [email protected]

Page 2: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Examples of corporate transactions that may have IP issues

♦ Licenses

♦ Investments

♦ M & A

♦ Loan Security

♦ Valuation

♦ S-1/10-K Risk Factors

♦ Employee/Consultant Agreements

2

Page 3: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Basic IP Law

♦ Patents♦ Covers the idea itself♦ Limited in time but absolute in scope♦ Coverage on a country-by-country basis

♦ Trademarks♦ Identifies the source of the goods or services♦ Unlimited in duration♦ Can be lost if term becomes generic

3

Page 4: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Basic IP Law

♦ Copyrights♦ Covers the expression of an idea, not the idea♦ Not limited to national boundaries♦ Life of the author plus 70 years

♦ Trade Secrets or Know How♦ Covers the idea itself♦ Limited by secrecy but can be lost if it loses secrecy♦ Does not cover independent invention or reverse engineering

♦ Domain Names♦ Covers the URL only♦ Has some trademark implications

4

Page 5: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Requirements for a Patentable Invention

♦ An invention must be:♦ Patentable Subject Matter♦ Novel♦ Non-Obvious♦ Enabled♦ Description to Meet Written Description Standard♦ Best Mode

5

Page 6: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Changes to Patent Law under AIA

♦ Under new Patent Act (March 16, 2013), First Inventor to File, not First to Invent is the basic test♦ Different scope of prior art♦ Grace Period for Inventor’s Disclosure

♦ New Post Grant Review Procedures:♦ Post Grant Review in 1st 9 Months after issuance – all grounds

of invalidity possible♦ Inter Partes review – After PGR – Only based on Patents and

Printed Publications♦ Derivation Proceedings – Did the Named Inventor get the Idea

from Someone Else?♦ Supplemental Examination – Patent Owner method to cure

even Inequitable Conduct – Becomes Ex Parte Reexamination

6

Page 7: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

IP Due Diligence Issues for any Transaction

♦ What type of IP exists?

♦ What is status of existing IP?

♦ Does it cover the product or process being sold or contemplated?

♦ Any additional IP available?

♦ What is licensed in and out?

♦ What is the competitive landscape?

7

Page 8: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

What is the Status of Current IP

♦ Are there patents that cover methods or products being used by the company?

♦ Does the IP cover anything that is being sold or licensed out?

♦ Are there patents on the products or methods?

♦ Are there trademarks covering anything sold?

♦ Where is the IP filed and where is it being used?

♦ What is issued versus pending?

♦ Are additional foreign (or US) applications possible?

♦ What is the duration of IP remaining?

8

Page 9: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Is the IP Protection Sufficient?

♦ Does the IP cover critical products or processes sufficient to protect the company against competitors?

♦ Does the IP provide a picket fence or just single product protection?

♦ How strong are any trademarks or copyrights?

♦ Is the IP overbroad; that is, is it broad without more limited claims?

♦ Does the IP somehow provide differentiation from competitors?

♦ Can the IP be made stronger?

♦ Has lifecycle management been considered and planned for?

9

Page 10: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Is Ownership of the IP Correct?

♦ Is the IP owned by proper entity?

♦ Have the inventors signed all necessary documents?

♦ Has anyone claimed that the inventorship is incorrect?

♦ Are there any licenses outstanding to third parties?

♦ Are there any licenses that expired and if so, are there any provisions that last past expiration?

♦ If the IP includes ex-US rights, have all owners agreed to any license?

10

Page 11: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Licensed-In Technology Problems

♦ Are the rights in any licensed-in technology sufficient to cover the current (or future) products?

♦ What are the scope of the licenses?

♦ Were any licenses limited to research and if so, is it defined?

♦ Are the licenses exclusive or nonexclusive?

♦ How many different licenses are used on a product or process that would generate royalties (and who will claim them)?

♦ Are there viable anti-stacking provisions?

♦ Are these combination products or are the methods unique?

Page 12: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

More Problems with Licenses

♦ Are there change of control clauses and how do they operate?

♦ What is the difference between a change of control clause and an assignment?

♦ Is there a restriction on assignment?♦ Can the license be transferred?♦ What is required to effectuate the transfer?♦ Difference between operation of law and assignment

♦ Are there termination clauses that are onerous?

♦ Are there indemnity clauses that are a problem?

♦ Are there arbitration or venue clauses that are problematic?

Page 13: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Additional IP Available?

♦ Are there pending applications that can support additional claims?

♦ Are continuations or divisionals possible?

♦ Is there any additional technology that can (or should) be patented?

♦ Is the scope of filing geographically commensurate with the distribution of the products?

♦ Are the trademarks registered where necessary?

♦ Have the trade secrets/know-how been properly protected?

Page 14: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Competition Issues

♦ Who are competitors in the field?

♦ What are the competitive technologies?

♦ Does the IP provide specific advantages?

♦ Will the IP protect potential market share?

♦ If the technology is licensed in, are the licenses sufficiently exclusive to keep out competitors?

♦ Are there possible antitrust issues from the licenses; e.g., tying or Sherman §or 2 issues?

Page 15: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Freedom To Operate

♦ How important is IP to the deal?

♦ Is the pertinent IP in the form of patents, trademarks or copyrights?

♦ Is a Freedom to Operate study valuable in terms of cost?

♦ Will using the technology infringe any rights of others?

♦ Are others using related technology who might have blocking IP issued or pending?

♦ Are licenses available?

Page 16: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Duration of IP

♦ When does the critical IP expire (or does it expire)?

♦ Is the additional IP sufficient for differentiation?

♦ Do trade secrets/know-how provide sufficient coverage?

♦ Can any of the IP be extended?

♦ Are there ways to practice Life Cycle Management that are worth exploring?

Page 17: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Areas to Investigate for Life Cycle Management

♦ Methods of use

♦ Manufacturing processes

♦ Delivery methods and carriers

♦ Formulations

♦ Dosing

Page 18: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Any FDA/Governmental Filings that have been made and IP Effect?

♦ Is this technology subject to Patent Term Extension?

♦ Is a Patent Term Extension still available?

♦ If so, has a Patent Term Extension been granted?

♦ What product or process should be the basis of the extension?

♦ Is there some form of exclusivity available?

♦ NCE, NFE, Orphan

Page 19: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

M & A/Investment Specific Issues

♦ Do the IP representations and warranties make sense?

♦ What reps and warranties have knowledge qualifiers?♦ Ownership?♦ Validity?♦ Noninfringement?

♦ What is the effect of the Knowledge qualifier?

♦ Are all liens being released?

♦ Who will own IP?

♦ Change of control clauses?

Page 20: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

S-1/10-K Issues

♦ Is the description of the IP accurate?

♦ Are the risk factors correct in terms of competitors and IP?

♦ Are there known threats that must be discussed?

♦ Is the description of any technology accurate?

♦ Have all liens on IP been released and recorded properly?

Page 21: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

Consultant and Employee Contracts

♦ Are there agreements on who owns any IP generated during employment or consulting?♦ Is the scope of the employment/consulting well defined?♦ Are there work-made-for-hire issues?

♦ Scope of employment issues♦ Consultants working for others♦ Employees not hired to invent

♦ Special work made for hire issues on copyright

♦ Duration of agreement and is there a conflict with another job?

♦ Inventions made before the agreement

Page 22: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

IP Due Diligence Checklist

22

Page 23: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

IP Due Diligence Checklist continued

23

Page 24: © 2013 Edwards Wildman Palmer LLP & Edwards Wildman Palmer UK LLP IP Issues in Transactions F.I.R.E. Series, University of Rochester May 14, 2013 Ralph.

IP Due Diligence Checklist continued

24